The information presented on this webpage is derived from a scientific presentation delivered at CRT on March 7, 2026. Cordis is sharing this content exclusively on this platform for academic and informational purposes. The presentation has not been altered or endorsed by Cordis. The content reflects the data and interpretations available at the time of the conference and may not include subsequent research, updates, or peer-reviewed publications. For authoritative guidance, please consult the relevant scientific literature or contact the authors directly.

The following clinical data evaluates SELUTION SLR Drug-Eluting Balloon in de novo coronary artery disease and other indicatcations not currently approved by the U.S. Food and Drug Administration (FDA)